Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Intravenous immunoglobulin is ineffective in the treatment of patients with chronic fatigue syndrome.

Vollmer-Conna U, Hickie I, Hadzi-Pavlovic D, Tymms K, Wakefield D, Dwyer J, Lloyd A.

Am J Med. 1997 Jul;103(1):38-43.

PMID:
9236484
2.

A double-blind, placebo-controlled trial of intravenous immunoglobulin therapy in patients with chronic fatigue syndrome.

Lloyd A, Hickie I, Wakefield D, Boughton C, Dwyer J.

Am J Med. 1990 Nov;89(5):561-8.

PMID:
2146875
3.

Immunologic and psychologic therapy for patients with chronic fatigue syndrome: a double-blind, placebo-controlled trial.

Lloyd AR, Hickie I, Brockman A, Hickie C, Wilson A, Dwyer J, Wakefield D.

Am J Med. 1993 Feb;94(2):197-203.

PMID:
8430715
4.

A controlled trial of intravenous immunoglobulin G in chronic fatigue syndrome.

Peterson PK, Shepard J, Macres M, Schenck C, Crosson J, Rechtman D, Lurie N.

Am J Med. 1990 Nov;89(5):554-60.

PMID:
2239975
5.

A multicenter, randomized, double-blind, placebo-controlled trial of high-dose intravenous immunoglobulin for oral corticosteroid-dependent asthma.

Kishiyama JL, Valacer D, Cunningham-Rundles C, Sperber K, Richmond GW, Abramson S, Glovsky M, Stiehm R, Stocks J, Rosenberg L, Shames RS, Corn B, Shearer WT, Bacot B, DiMaio M, Tonetta S, Adelman DC.

Clin Immunol. 1999 May;91(2):126-33.

PMID:
10227804
6.

Cognitive behavioural therapy in chronic fatigue syndrome: a randomised controlled trial of an outpatient group programme.

O'Dowd H, Gladwell P, Rogers CA, Hollinghurst S, Gregory A.

Health Technol Assess. 2006 Oct;10(37):iii-iv, ix-x, 1-121.

7.

Mitoxantrone: a review of its use in multiple sclerosis.

Scott LJ, Figgitt DP.

CNS Drugs. 2004;18(6):379-96. Review.

PMID:
15089110
8.

A placebo-controlled, double-blind, randomized controlled trial of a natural killer cell stimulant (BioBran MGN-3) in chronic fatigue syndrome.

McDermott C, Richards SC, Thomas PW, Montgomery J, Lewith G.

QJM. 2006 Jul;99(7):461-8. Epub 2006 Jun 29.

PMID:
16809351
9.
10.

Immunological and psychological dysfunction in patients receiving immunotherapy for chronic fatigue syndrome.

Hickie I, Lloyd A, Wakefield D.

Aust N Z J Psychiatry. 1992 Jun;26(2):249-56.

PMID:
1642616
11.

A controlled clinical trial with a specifically configured RNA drug, poly(I).poly(C12U), in chronic fatigue syndrome.

Strayer DR, Carter WA, Brodsky I, Cheney P, Peterson D, Salvato P, Thompson C, Loveless M, Shapiro DE, Elsasser W, et al.

Clin Infect Dis. 1994 Jan;18 Suppl 1:S88-95.

PMID:
8148460
12.

Double-blind placebo-controlled study of the efficacy of oral terfenadine in the treatment of chronic fatigue syndrome.

Steinberg P, McNutt BE, Marshall P, Schenck C, Lurie N, Pheley A, Peterson PK.

J Allergy Clin Immunol. 1996 Jan;97(1 Pt 1):119-26.

PMID:
8568124
13.

Treatment with staphylococcus toxoid in fibromyalgia/chronic fatigue syndrome--a randomised controlled trial.

Zachrisson O, Regland B, Jahreskog M, Jonsson M, Kron M, Gottfries CG.

Eur J Pain. 2002;6(6):455-66.

PMID:
12413434
14.

A randomized, double-blind placebo-controlled trial of moclobemide in patients with chronic fatigue syndrome.

Hickie IB, Wilson AJ, Wright JM, Bennett BK, Wakefield D, Lloyd AR.

J Clin Psychiatry. 2000 Sep;61(9):643-8.

PMID:
11030484
15.

Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trial.

Fazekas F, Lublin FD, Li D, Freedman MS, Hartung HP, Rieckmann P, Sørensen PS, Maas-Enriquez M, Sommerauer B, Hanna K; PRIVIG Study Group; UBC MS/MRI Research Group.

Neurology. 2008 Jul 22;71(4):265-71. doi: 10.1212/01.wnl.0000318281.98220.6f.

PMID:
18645164
16.

Does methylphenidate reduce the symptoms of chronic fatigue syndrome?

Blockmans D, Persoons P, Van Houdenhove B, Bobbaers H.

Am J Med. 2006 Feb;119(2):167.e23-30.

PMID:
16443425
17.

Intravenous immunoglobulin therapy in multifocal motor neuropathy: a double-blind, placebo-controlled study.

Léger JM, Chassande B, Musset L, Meininger V, Bouche P, Baumann N.

Brain. 2001 Jan;124(Pt 1):145-53.

PMID:
11133794
19.

Therapeutic effects of oral NADH on the symptoms of patients with chronic fatigue syndrome.

Forsyth LM, Preuss HG, MacDowell AL, Chiazze L Jr, Birkmayer GD, Bellanti JA.

Ann Allergy Asthma Immunol. 1999 Feb;82(2):185-91.

PMID:
10071523
20.

Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder.

Trivedi MH, Pigotti TA, Perera P, Dillingham KE, Carfagno ML, Pitts CD.

J Clin Psychiatry. 2004 Oct;65(10):1356-64.

PMID:
15491239

Supplemental Content

Support Center